**Summary**
Cirata PLCs preliminary results for FY25 highlight significant strategic and financial achievements. The company reported its strongest Data Integration (DI) bookings since 2017, with FY25 DI bookings at $13.2 million, a 181% increase year-on-year. Q4 FY25 DI bookings reached $9.8 million, the highest quarterly performance in the companys history. Cirata secured its largest direct and OEM contracts, a $3.1 million three-year deal with a US insurer and a $6.7 million three-year agreement via IBM, respectively. The divestment of the DevOps business for $3.4 million allowed Cirata to focus exclusively on DI, reducing its annualised cost base to $12-13 million, less than one-third of its peak.
Financial highlights include a 96% increase in total bookings to $13.9 million, a 77% rise in total revenue to $13.6 million, and a 74% decrease in adjusted EBITDA loss to $3.8 million. Cash and cash equivalents stood at $4.0 million, with short-term trade receivables of $3.4 million, totaling $7.4 million. The company targets cash flow positivity in Q1 FY26 and aims for cash flow break-even for FY26. The FCA investigation concluded with no further action, and Cirata launched Cirata Symphony, a new Data Orchestration platform.
Management emphasized the focus on building predictability, deepening strategic partnerships, and expanding within the Global 2000 customer base. Despite the inherent lumpiness of enterprise software revenues, Cirata is positioned for sustainable growth, supported by its strategic repositioning and market opportunities in Data Integration and Orchestration.
| Financial Metric | 2024 | 2025 | Year-on-Year Change |
|---|---|---|---|
| Total Bookings ($m) | 7.1 | 13.9 | 96% Increase |
| Data Integration Bookings ($m) | 4.7 | 13.2 | 181% Increase |
| Total Revenue ($m) | 7.7 | 13.6 | 77% Increase |
| Revenue from Continuing Operations ($m) | 4.6 | 11.9 | 157% Increase |
| Revenue from Discontinued Operations ($m) | 3.1 | 1.7 | 45% Decrease |
| Total Cash Overheads ($m) | 20.6 | 16.1 | 22% Decrease |
| Cash Overheads Continuing Operations ($m) | 18.5 | 14.9 | 19% Decrease |
| Cash Overheads Discontinued Operations ($m) | 2.1 | 1.1 | 48% Decrease |
| Adjusted EBITDA Loss ($m) | -14.4 | -3.8 | 74% Decrease in Loss |
| Operating Loss ($m) | -15.8 | -4.6 | 71% Decrease in Loss |
| Cash and Cash Equivalents ($m) | 9.7 | 4.0 | 59% Decrease |
| Short-term Trade Receivables ($m) | 3.4 | 3.4 | 0% Change |
| Combined Cash and Short-term Receivables ($m) | 13.1 | 7.4 | 44% Decrease |